正在迅速成長(zhǎng)的杭州多禧生物科技有限公司位于中國(guó)的“天堂”城市杭州。公司由五位在美國(guó)生物制藥界分別有二十多年經(jīng)驗(yàn)的海歸科學(xué)家創(chuàng)立，致力于研發(fā)新一代被譽(yù)為“生物”的抗體-藥物共軛體（ADC）抗癌藥物，志在挽救成千上萬(wàn)癌癥患者的生命。我們團(tuán)隊(duì)成員曾作為技術(shù)骨干為當(dāng)今治療乳腺癌最有效的ADC藥物Kadcyla的成功上市做出重要貢獻(xiàn)。擁有數(shù)項(xiàng)自主知識(shí)產(chǎn)權(quán)的多禧生物正在迅速成為本領(lǐng)域的全球領(lǐng)跑者之一，現(xiàn)在加盟本公司恰逢其時(shí)。如果您是有活力的、夢(mèng)想成功的專(zhuān)業(yè)人士，杭州多禧生物科技有限公司將為您提供一片發(fā)現(xiàn)、應(yīng)用和發(fā)展才能的沃土。 Hangzhou DAC Biotech Co.，Ltd. is a rapidly growing start-up located in the “paradise” city of China. As a biotech company established by five oversea returnee scientists who each had more than 20 years of experience in the US pharmaceutical industry respectively, we focus on developing next generation antibody-drug conjugates (ADC) or so-called “biological missiles” for cancer treatment. The goal is to develop a technology to save hundreds and thousands of cancer patients’ lives. As key scientists in a pioneering ADC company previously, our team members had made crucial contributions to the success of Kadcyla, an ADC that is currently the most efficacious drug for the treatment of breast cancer. With several proprietary technologies and related patents in hand, our company is quickly becoming one of the global leaders in the development of ADC platform technology. It is an exciting time to work at Hangzhou DAC Biotech. If you are a dynamic, success-driven professional, our company is the place where you can identify, utilize and develop your talents. 公司優(yōu)勢(shì) 1. 員工享有股權(quán)激勵(lì)和其他福利、保險(xiǎn)、帶薪休假、年度體檢、和午餐補(bǔ)貼等； 2. 公司關(guān)心員工的前程，并將大力培育員工的成長(zhǎng)； 3. 公司尊重員工，并將為員工提供各方面的權(quán)益保護(hù)； 4. 對(duì)于員工所作出的突出貢獻(xiàn)，公司也將格外突出地獎(jiǎng)勵(lì)； 5. 公司會(huì)為員工準(zhǔn)備不定期的驚喜。 簡(jiǎn)歷投放：email: 或：浙江杭州市錢(qián)塘區(qū)下沙街道喬新路369號(hào)，郵編310018